Advertisement
Screener

COMPASS PATHWAYS PLC (CMPS) Auditor

COMPASS PATHWAYS PLC Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-24: Fiscal year end 2025-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
  • 2025-02-27: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 876; Location Reading, United Kingdom.
  • 2024-02-29: Fiscal year end 2023-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 876; Location Reading, United Kingdom.
  • 2023-02-28: Fiscal year end 2022-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 876; Location Reading, United Kingdom.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-242025-12-31PricewaterhouseCoopers LLP238Boston, MassachusettsNo
2025-02-272024-12-31PricewaterhouseCoopers LLP876Reading, United KingdomNo
2024-02-292023-12-31PricewaterhouseCoopers LLP876Reading, United KingdomNo
2023-02-282022-12-31PricewaterhouseCoopers LLP876Reading, United KingdomNo
2022-02-242021-12-31PricewaterhouseCoopers LLP876Reading, United KingdomYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
Septerna, Inc. (SEPN)United States$1.783B-63.01
Xencor Inc (XNCR)United States$1.776B-7.33
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82